Povertyweed Pollen Allergy: The Hidden Amaranthaceae Fall Weed Allergen
Povertyweed pollen allergy is a wind-pollinated weed allergy caused by Monolepis nuttalliana, a member of the Amaranthaceae family that includes Russian thistle and lamb's quarters. It affects an estimated 5 to 12 percent of allergy patients in the western and central United States during summer and early fall. Symptoms include sneezing, nasal congestion, itchy eyes, and asthma flares. Cross-reactivity across the Amaranthaceae family means sensitization to one member often predicts reactivity to all.
Free · 5 min · Insurance accepted
Key facts
Povertyweed (Monolepis nuttalliana) is an Amaranthaceae weed producing wind-dispersed pollen cross-reactive with Russian thistle, kochia, and other chenopod/amaranth species.
The Amaranthaceae family contains over 2,500 species including many agriculturally important weeds; shared profilin and LTP allergen families drive cross-reactivity across the group.
Late summer weed pollen (August–October) in the western US is dominated by Amaranthaceae species including Russian thistle, kochia, and pigweed — povertyweed sensitization overlaps this network.
Patients sensitized to chenopod/amaranth weeds often show co-sensitization to grass and ragweed, complicating attribution of individual late-summer symptoms to specific species.
Allergen immunotherapy covering Russian thistle (Salsola) and pigweed (Amaranthus) extracts provides clinical benefit against the Amaranthaceae weed cross-reactive group.
What Is Povertyweed Pollen Allergy?
Povertyweed pollen allergy is an IgE-mediated respiratory condition triggered by airborne pollen from Monolepis nuttalliana, a small, inconspicuous wind-pollinated weed in the Amaranthaceae family.
This family — formerly split as Chenopodiaceae — includes some of the most potent fall weed allergens in North America: Russian thistle (Salsola kali), kochia (Bassia scoparia), lamb's quarters (Chenopodium album), and saltbush (Atriplex species).
Povertyweed grows in disturbed alkaline soils across the Great Basin and Great Plains, often in dry washes, roadside margins, and overgrazed rangelands. It is small enough — typically 5 to 25 centimeters tall — that most patients never notice it. Unlike the showy goldenrod that patients wrongly blame for fall symptoms, povertyweed is genuinely wind-pollinated and releases lightweight pollen into the air during July through September.
No species-specific allergens have been characterized for Monolepis nuttalliana, but extensive extract-level cross-reactivity across Amaranthaceae members means that sensitization to any family member — Russian thistle, lamb's quarters, or kochia — functionally predicts reactivity to povertyweed pollen. Patients in the western US reporting late-summer weed allergy symptoms are frequently sensitized to this broader Amaranthaceae network, even if they have never heard of povertyweed.
Symptoms of Povertyweed Pollen Allergy
Recognizing symptoms early helps you get the right treatment faster.
Sneezing
mildRepetitive sneezing fits triggered by pollen inhalation are among the earliest and most common symptoms, often worse in morning when pollen counts peak.
Nasal congestion
moderateHistamine-driven mucosal swelling blocks nasal passages, causing mouth breathing, disrupted sleep, and a sensation of pressure across the face.
Runny nose (rhinorrhea)
mildWatery, clear nasal discharge occurs as part of the inflammatory cascade; thick or discolored discharge suggests secondary bacterial infection.
Itchy, watery eyes
mildAllergic conjunctivitis with bilateral eye itch, tearing, and redness is common during peak Amaranthaceae pollen exposure in late summer.
Postnasal drip
mildMucus draining from the nasal passages into the throat triggers chronic cough, throat clearing, and a scratchy throat sensation.
Wheezing and chest tightness
severePollen-triggered bronchospasm causes audible wheezing and chest tightness — a hallmark of allergic asthma that requires medical evaluation.
Cough
moderateA dry, nonproductive cough may persist throughout the Amaranthaceae pollen season, worsening at night and during outdoor activity.
Fatigue and reduced concentration
moderateChronic nasal obstruction and poor sleep quality from nighttime congestion produce daytime fatigue and cognitive impairment during the pollen season.
When to see a doctor
Povertyweed pollen allergy produces the full spectrum of IgE-mediated respiratory symptoms characteristic of weed pollen sensitization. Because Amaranthaceae family members are associated with both rhinoconjunctivitis and allergic asthma — Russian thistle in particular is linked to severe disabling asthma in the western US — patients should not dismiss late-summer respiratory symptoms as a minor seasonal inconvenience. Symptoms typically begin within minutes to hours of pollen exposure and worsen on dry, windy days when airborne pollen counts peak. Patients with concurrent sensitization to other Amaranthaceae members may experience a prolonged symptom season from July through October. Nasal symptoms predominate, but ocular, respiratory, and systemic manifestations occur in moderate-to-severe cases. If you experience wheezing, chest tightness, or difficulty breathing during peak Amaranthaceae season, seek prompt medical evaluation — these may indicate allergic asthma requiring controller medications beyond simple antihistamines.
Povertyweed Pollen and Asthma
Amaranthaceae weed pollen exposure is directly linked to allergic asthma exacerbations across the western and central United States. Russian thistle — the best-studied member of this family — is associated with severe disabling asthma, not merely mild seasonal rhinitis. Because povertyweed shares the same cross-reactive protein network, sensitized patients with underlying airway hyperreactivity face meaningful risk of bronchospasm during peak pollen season. Studies of Amaranthaceae pollen-driven asthma in arid western regions show that emergency department visits for asthma spike during the July-October weed pollen window, correlating with ambient Chenopodium-Amaranthaceae pollen counts. Patients who experience cough, wheezing, or chest tightness during late summer should discuss the possibility of pollen-triggered asthma with a board-certified allergist.
Potential Complications of Povertyweed Pollen Allergy
Untreated Amaranthaceae weed pollen allergy can progress beyond seasonal annoyance into clinically significant chronic conditions. The July-through-October pollen season in the western US is long enough for persistent nasal inflammation to impair mucociliary clearance and promote secondary bacterial sinusitis. Patients with concurrent sensitization to multiple Amaranthaceae members, grasses, and other regional pollens may experience symptoms for five to six months of the year — effectively transitioning from seasonal to perennial rhinitis. The asthma risk is the most serious complication. Epidemiological data from the western US demonstrate that Chenopod/Amaranthaceae pollen sensitization significantly increases the risk of developing allergic asthma, particularly in patients with untreated rhinitis (the united airway hypothesis). Sleep disruption from chronic nocturnal congestion compounds cognitive and occupational impairment during the long western pollen season.
Chronic sinusitis
Persistent nasal inflammation from months of Amaranthaceae pollen exposure impairs sinus drainage, predisposing to recurrent or chronic bacterial sinus infections.
Allergic asthma development
Untreated Amaranthaceae rhinitis is associated with progression to allergic asthma — Russian thistle sensitization specifically correlates with severe asthma in the western US.
Eustachian tube dysfunction
Chronic nasal inflammation can impair middle ear pressure equalization, causing ear fullness, popping, and recurrent otitis media in susceptible individuals.
Sleep disruption and fatigue
Nocturnal nasal congestion disrupts sleep architecture, producing daytime somnolence, irritability, and reduced work or school performance across the multi-month season.
What Causes Povertyweed Pollen Reactions?
Povertyweed pollen reactions are caused by repeated inhalation of airborne Monolepis nuttalliana pollen grains during the summer-to-fall growing season. The plant is monoecious and wind-pollinated, producing small quantities of lightweight pollen from inconspicuous flower clusters nestled in leaf axils. While individual plants produce less pollen than Russian thistle or lamb's quarters, povertyweed often grows in dense carpets across alkaline flats, collectively contributing meaningful pollen loads to the regional aeroallergen burden.
Povertyweed / Nuttall's monolepis
Monolepis nuttalliana
Russian thistle / tumbleweed / saltwort
Salsola kali
Lamb's quarters / fat hen / white goosefoot
Chenopodium album
Kochia / burning bush (the weed, not Euonymus)
Bassia scoparia
Four-wing saltbush
Atriplex canescens
Redroot pigweed
Amaranthus retroflexus
How it works
Povertyweed pollen allergy follows the Type I (IgE-mediated) hypersensitivity pathway. On initial exposure, the immune system generates IgE antibodies against Amaranthaceae pollen proteins. These IgE molecules bind to mast cells in the nasal mucosa, conjunctiva, and bronchial lining. On re-exposure, inhaled povertyweed pollen proteins cross-link the bound IgE, triggering mast cell degranulation with release of histamine, leukotrienes, and prostaglandins — producing the sneezing, congestion, eye itch, and bronchospasm characteristic of allergic rhinoconjunctivitis and allergic asthma.
The broader Amaranthaceae cross-reactivity network is the critical clinical context. All four major Amaranthaceae genera — Chenopodium, Salsola, Amaranthus, and Bassia — cross-react extensively at extract level, primarily via shared profilins and polcalcins. Pollen grains of Chenopodium and Amaranthus are morphologically indistinguishable under light microscopy, complicating pollen-count attribution. A patient sensitized to lamb's quarters in the Midwest may experience symptoms from povertyweed exposure when traveling through the Great Basin — the same IgE antibodies recognize shared protein epitopes across the family.
Geographic expansion of disturbed alkaline habitat through drought, overgrazing, and land-use change is increasing povertyweed distribution across the western states, gradually broadening the population exposed to this unrecognized aeroallergen.
Risk factors to watch for
Residence in the Great Basin or Great Plains
Povertyweed thrives in alkaline, disturbed soils common across Nevada, Utah, Wyoming, Colorado, and Montana — patients in these regions face consistent summer exposure.
Known Amaranthaceae sensitization
Patients already sensitized to Russian thistle, lamb's quarters, or kochia are likely to react to povertyweed pollen through shared cross-reactive proteins.
Outdoor occupations in arid western regions
Ranchers, highway workers, and construction workers in the Great Basin face amplified exposure during the July–September pollen season.
Family history of atopy
A genetic predisposition to produce IgE antibodies increases susceptibility to sensitization from any Amaranthaceae pollen, including povertyweed.
The Allergy Cascade
Exposure
Allergen contact
Detection
Immune recognition
IgE Response
Antibody production
Mast Cells
Histamine release
Symptoms
Allergic reaction
1.Exposure
Allergen contact
2.Detection
Immune recognition
3.IgE Response
Antibody production
4.Mast Cells
Histamine release
5.Symptoms
Allergic reaction
How Is Povertyweed Pollen Allergy Diagnosed?
Diagnosing povertyweed pollen allergy requires identifying the broader Amaranthaceae sensitization pattern, because no species-specific Monolepis test extract exists in standard US allergy panels. The clinical approach uses the well-characterized Chenopod/Amaranthaceae markers — Chenopodium album (lamb's quarters) and Salsola kali (Russian thistle) — as proxies, since extensive cross-reactivity means a positive result to any family member predicts reactivity across the family. Skin prick testing with Chenopodium and Salsola extracts is the frontline diagnostic tool. A wheal ≥3 mm larger than the negative control indicates IgE sensitization. For patients in the Great Basin or Great Plains reporting July-September symptoms, a positive Amaranthaceae panel combined with the correct geographic and temporal exposure pattern strongly supports the diagnosis. At-home allergy testing services such as Curex provide panels covering 40+ common environmental allergens — including Chenopod/Amaranthaceae weeds — with results typically within 5 days and insurance coverage often available. This allows patients in remote western regions to establish their sensitization profile without traveling to a specialist. A board-certified allergist can then correlate results with local pollen calendars to confirm which weeds are driving symptoms.
Skin prick test (Chenopod/Amaranthaceae panel)
Standardized extracts of Chenopodium album and Salsola kali are applied to the forearm or back. A positive wheal-and-flare response indicates IgE sensitization to the Amaranthaceae family, predicting cross-reactivity with povertyweed.
Specific IgE blood test (serology)
ImmunoCAP or similar assays measure circulating IgE to Chenopodium and Salsola allergens. Useful for patients on antihistamines or with skin conditions preventing prick testing.
Component-resolved diagnostics
Molecular testing for specific allergens like Sal k 1 (species-specific to Salsola) and Che a 1 (primary Chenopodium marker) can distinguish primary versus cross-reactive sensitization within the family.
Test from home with Curex
Skip the clinic visit. Curex sends an at-home allergy test kit to your door, and a board-certified allergist reviews your results to build a personalized treatment plan.
Take the allergy quizCompare Treatment Options
See how different approaches stack up for managing your allergy symptoms long-term.
Traditional
Allergy Shots (SCIT)
Immunotherapy (SLIT)
RecommendedTreats root cause
Long-lasting relief
At-home treatment
No office visits
Low side effects
Estimated cost
Traditional
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Allergy Shots (SCIT)
- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
Immunotherapy (SLIT)
Recommended- Treats root cause
- Long-lasting relief
- At-home treatment
- No office visits
- Low side effects
- Estimated cost
The long-term solution to allergies
Instead of masking symptoms, immunotherapy retrains your immune system.
For patients whose late-summer symptoms persist despite medication — particularly those in the western US facing four months of continuous Amaranthaceae pollen from July through October — allergen immunotherapy offers the only disease-modifying treatment. Rather than masking symptoms each season, immunotherapy gradually retrains the immune system to tolerate the pollen proteins driving the allergic response. The treatment targets the Amaranthaceae family as a unit. Because povertyweed, Russian thistle, lamb's quarters, kochia, and saltbush share extensive cross-reactive IgE epitopes, immunotherapy formulated with Chenopodium and Salsola extracts provides cross-protection across the entire family. A board-certified allergist determines the optimal extract combination based on the patient's sensitization profile and regional pollen exposure. Sublingual immunotherapy drops, available through providers like Curex starting at $39/month, allow patients to undergo desensitization at home — eliminating the weekly clinic visits required for allergy shots. This is especially practical for patients in rural western states where specialist access is limited. Plans are typically covered by most insurance, and the at-home convenience improves long-term adherence through the 3-to-5-year treatment course.
Comprehensive weed pollen panel testing
Identify the full Amaranthaceae sensitization profile — Chenopodium, Salsola, Bassia, Atriplex — along with any concurrent grass or tree pollen allergies.
Custom allergen formulation
Based on confirmed sensitization, allergen drops or injections are formulated with standardized Chenopod/Amaranthaceae extracts to target the cross-reactive family.
Gradual dose escalation
Over 3-6 months, allergen doses increase incrementally to build immune tolerance while monitoring for adverse reactions.
Maintenance and long-term tolerance
After reaching maintenance dose, continued treatment for 3-5 years produces sustained symptom reduction that persists after discontinuation.
“Clinical trials demonstrate 60-80% symptom reduction in patients who complete the full immunotherapy course for weed pollen allergy”
Treat your Povertyweed Pollen allergy at the source
See if at-home sublingual allergy drops fit your allergies — a 2-minute quiz, designed by board-certified allergists, with no needles and no clinic visits.
- 4.8/5Patient rating
- From $39/moWith insurance
- 50K+Patients treated
- HSA/FSAEligible
Living With Povertyweed Pollen Allergy
Managing povertyweed pollen allergy is achievable once you understand that you are managing an Amaranthaceae family sensitization — not a single-species problem. This broader perspective explains why symptoms extend beyond povertyweed's July-September window: Russian thistle, kochia, and lamb's quarters push Amaranthaceae pollen exposure into October in warmer regions. A symptom diary tracking daily severity against regional pollen count data helps identify which Amaranthaceae members are your primary triggers and which days pose the greatest risk. This information is invaluable for an allergist designing an immunotherapy protocol and for planning outdoor activities around peak exposure periods. For patients in rural western communities where specialist access is limited, telehealth allergy consultations combined with at-home testing provide a practical pathway to diagnosis and treatment without multiple drives to an urban allergy clinic.
Understand the family-level problem
Povertyweed sensitization means you likely react to Russian thistle, lamb's quarters, and kochia too. Ask your allergist to test the full Amaranthaceae panel so treatment addresses the entire cross-reactive family, not just one species.
Plan around the extended weed season
Amaranthaceae pollen in the western US runs July through October. Adjust your medication timing, outdoor activities, and travel plans to account for the full four-month window, not just the povertyweed peak.
Protect your sleep quality
Nocturnal congestion from weed pollen allergy disrupts sleep architecture. Use a HEPA filter in the bedroom, elevate the head of your bed, and consider intranasal corticosteroids before sleep during peak season.
Seasonal Patterns
July - August
high intensity
September - October
medium intensity
Prevention Tips
Monitor regional pollen counts
Use the National Allergy Bureau or weather app pollen tracking to identify high Amaranthaceae pollen days and limit outdoor exposure accordingly.
Keep windows closed during peak season
Close windows and use air conditioning with HEPA filtration during July-September when Amaranthaceae weed pollen counts peak in the western US.
Shower after outdoor activity
Pollen trapped in hair and clothing continues causing indoor exposure — showering and changing clothes after time outdoors removes this reservoir.
Pre-season medication start
Begin intranasal corticosteroids 1-2 weeks before July pollen onset for optimal inflammatory control through the season.
Manage property vegetation
Remove povertyweed and other Amaranthaceae weeds from your property before they flower in July to reduce local pollen load.
Outlook for Povertyweed Pollen Allergy
The long-term outlook for povertyweed pollen allergy is favorable with appropriate treatment. Pharmacotherapy provides reliable season-to-season symptom control, and allergen immunotherapy targeting the Amaranthaceae family offers disease modification that persists after treatment discontinuation. Most patients achieve 60-80% symptom reduction with immunotherapy and report significantly improved quality of life during the fall weed pollen season. However, the underlying sensitization is lifelong, and climate trends suggest that warmer temperatures and increased aridity may extend Amaranthaceae pollen seasons and expand the geographic range of these weeds into previously unaffected areas. Early treatment — before rhinitis progresses to asthma — produces the best long-term outcomes.
Key takeaways
Povertyweed pollen allergy is part of a broader Amaranthaceae weed sensitization affecting millions of Americans in the western US
No species-specific Monolepis allergens are characterized, but family-level cross-reactivity makes Chenopod/Salsola panel testing clinically sufficient
Untreated Amaranthaceae pollen allergy carries significant asthma risk — early intervention is important
Allergen immunotherapy targeting Chenopod/Amaranthaceae extracts provides lasting disease modification
Diet and Povertyweed Pollen Allergy
Diet is not a primary factor in managing povertyweed pollen allergy. Unlike birch or mugwort pollen, Amaranthaceae weed pollens have limited established pollen-food cross-reactivity networks. Profilin pan-allergens are present in all Amaranthaceae pollens and could theoretically trigger oral allergy syndrome with raw fruits and vegetables in profilin-sensitized individuals, but this cross-reactivity is clinically significant in only 10-20% of pollen-allergic patients. Anti-inflammatory dietary patterns rich in omega-3 fatty acids and antioxidants may support general immune modulation but have not been specifically studied for Amaranthaceae pollen allergy.
Foods that help
Fatty fish (salmon, sardines)
Omega-3 fatty acids may support anti-inflammatory immune modulation during allergy season.
Quercetin-rich foods (onions, berries)
Quercetin has mast cell-stabilizing properties in laboratory studies, though clinical evidence for allergy symptom reduction is limited.
Povertyweed is a minor member of a major allergenic family. Patients with chenopod/amaranth sensitization living in the western US face a late-summer weed burden that includes Russian thistle, kochia, pigweed, and povertyweed — all sharing cross-reactive allergen proteins. Immunotherapy targeting the major Amaranthaceae species in a region provides coverage across the group, eliminating the need for species-specific povertyweed investigation.
Frequently Asked Questions
Yes, povertyweed (Monolepis nuttalliana) belongs to the same botanical family — Amaranthaceae (formerly Chenopodiaceae) — as Russian thistle (Salsola kali), lamb's quarters (Chenopodium album), kochia (Bassia scoparia), and saltbush (Atriplex). All these plants share extensive cross-reactive pollen proteins, meaning IgE antibodies generated against one family member typically recognize pollen from the others. This is why allergists test for the broader Chenopod-Amaranthaceae panel rather than for individual species. If you test positive for Russian thistle or lamb's quarters on a skin prick test, you are very likely to react to povertyweed pollen as well.
Not necessarily. Amaranthaceae weeds (povertyweed, Russian thistle, lamb's quarters, kochia) share extensive cross-reactivity within their family, so sensitization to one typically predicts reactivity to the others. However, this family-level cross-reactivity does not extend to unrelated weed families. Ragweed (Ambrosia, Asteraceae) and mugwort (Artemisia, Asteraceae) use entirely different allergen protein families — a patient could be sensitized to Amaranthaceae weeds without reacting to ragweed, or vice versa. That said, many weed-allergic patients are poly-sensitized to multiple families. A comprehensive allergy panel identifies which families are specifically driving your symptoms.
Povertyweed (Monolepis nuttalliana) grows primarily in disturbed alkaline soils across the Great Basin and Great Plains — states including Nevada, Utah, Wyoming, Colorado, Montana, Idaho, and eastern Oregon. It colonizes dry washes, roadside margins, overgrazed rangelands, and alkaline flats. The plant is small (5 to 25 centimeters tall) and inconspicuous, with fleshy leaves and tiny greenish flowers nestled in leaf axils. Most patients exposed to povertyweed pollen never notice the plant itself. It is rare or absent in the humid eastern United States and is not found in most urban settings.
Povertyweed pollen season spans July through September in most of its range across the western United States. Peak pollen production occurs in August when the plants are fully mature and hot, dry winds maximize pollen dispersal. However, the broader Amaranthaceae weed pollen season extends from July into October because other family members — particularly Russian thistle and kochia — continue pollinating after povertyweed finishes. Patients sensitized to the Amaranthaceae family should expect symptoms across this entire four-month window and plan their pharmacotherapy accordingly.
Amaranthaceae weed pollen is directly associated with allergic asthma in the western and central United States. Russian thistle — the best-studied family member — is linked to severe disabling asthma, not merely mild seasonal rhinitis. Because povertyweed shares the same cross-reactive protein network, sensitized patients with underlying airway hyperreactivity face meaningful bronchospasm risk during peak pollen season. If you experience coughing, wheezing, or chest tightness during late summer in the western US, discuss the possibility of pollen-triggered asthma with your allergist. Early treatment with inhaled corticosteroids can prevent progression.
Standard allergy panels include the most clinically significant representative species from each allergenic family. For Amaranthaceae weeds, Chenopodium album (lamb's quarters) and Salsola kali (Russian thistle) serve as the panel representatives because they have characterized allergens and well-validated test extracts. Because all Amaranthaceae members cross-react extensively at the protein level, a positive test to Chenopodium or Salsola accurately predicts sensitization to povertyweed. Adding a separate Monolepis extract would increase cost and testing burden without improving diagnostic accuracy — family-level testing is clinically sufficient.
No, though both belong to the Amaranthaceae family and can cause cross-reactive pollen allergy. Povertyweed (Monolepis nuttalliana) is a small, fleshy-leaved plant of alkaline western soils. Pigweed most commonly refers to redroot pigweed (Amaranthus retroflexus), a taller, more widespread weed found across the entire United States. Both are wind-pollinated and release clinically relevant pollen, and both participate in the broader Amaranthaceae cross-reactivity network. From an allergy management perspective, the distinction matters less than the shared family membership — treatment targets the family-level sensitization regardless of which specific species is present.
Povertyweed belongs to the Amaranthaceae family, while ragweed belongs to the Asteraceae family — they are botanically unrelated and use entirely different allergen protein families. Ragweed's major allergen (Amb a 1, a pectate lyase) has no significant cross-reactivity with Amaranthaceae proteins like Sal k 1 or Che a 1. The two families also differ in peak geographic dominance: ragweed is the primary fall weed allergen east of the Rocky Mountains, while Amaranthaceae weeds (including povertyweed) dominate fall weed pollen in the western and central US. A patient can be allergic to one family without reacting to the other, though poly-sensitization to both is common.
Climate projections suggest that warmer temperatures, increased aridity, and expanding disturbed-soil habitat will benefit Amaranthaceae weeds including povertyweed. Extended growing seasons mean longer pollen production windows, and drought conditions favor drought-adapted species like povertyweed and Russian thistle over less tolerant competitors. Studies of arid-region weeds show increased pollen production under elevated carbon dioxide concentrations. These trends suggest that Amaranthaceae weed allergy may become more prevalent and severe in coming decades, particularly as these species expand into areas previously too cool or moist to support them.
Yes, new-onset allergic sensitization can develop at any age. Adults who relocate to the Great Basin or Great Plains and encounter Amaranthaceae weed pollen for the first time may develop IgE sensitization after one or more exposure seasons. The classic presentation is an adult who never had fall allergies before moving to Nevada, Utah, or Wyoming and begins experiencing rhinoconjunctivitis symptoms during their second or third summer in the region. This is consistent with the sensitization timeline — initial exposure primes the immune system, and subsequent seasons trigger symptomatic disease. An allergy evaluation after the first symptomatic season enables early intervention.
Medical References
- [1]Weber RW. Cross-reactivity of pollen allergens: recommendations for immunotherapy vaccines. Curr Opin Allergy Clin Immunol 2005;5(6):563-569.
- [2]Villalba M, RodrĂguez R, Batanero E. The spectrum of olive pollen allergens. From structures to diagnosis and treatment. Methods 2014;66(1):44-54.
- [3]American Academy of Allergy, Asthma & Immunology (AAAAI). Weed pollen allergy. AAAAI Conditions Library.
- [4]RodrĂguez R, Villalba M, Batanero E, et al. Emerging pollen allergens. Biomed Pharmacother 2007;61(1):86-99.
- [5]Bousquet J, Khaltaev N, Cruz AA, et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update. Allergy 2008;63 Suppl 86:8-160.
- [6]D'Amato G, Cecchi L, Bonini S, et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007;62(9):976-990.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Ready to treat your Povertyweed Pollen allergies for good?
Get a personalized treatment plan from board-certified allergists, delivered to your door.
Reviewed by board-certified allergists. Personalized treatment plans based on your at-home IgE test, not generic protocols.
